Ironwood Pharmaceuticals | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Almirall EUR 374.4M 2.7M 2025-03
Alnylam Pharmaceuticals USD 1.11B 94.03M 2025-06
Amarin USD 119.52M 1.51M 2025-03
Ardelyx USD 48.65M 8.78M 2024-12
Astellas Pharma JPY 188.37B 8.51B 2025-03
AstraZeneca USD 7.06B 1.83B 2025-06
Charles River Laboratories USD 229.36M 34.75M 2025-03
Exact Sciences USD 6.11M 773K 2025-03
Halozyme Therapeutics USD 176.33M 60.48M 2025-03
Incyte USD 2.42B 13.08M 2025-06
Ironwood Pharmaceuticals USD 88.56M 348K 2024-12
MacroGenics USD 182.84M 3.22M 2024-12
Moderna USD 1.62B 304M 2025-03
Myriad Genetics USD 91.8M 10.6M 2025-03
Pacira USD 283.61M 6.84M 2025-03
PTC Therapeutics USD 2.03B 1.25B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Takeda JPY 350.01B 35.11B 2025-06
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03


Ironwood Pharmaceuticals Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Aug 2025.